Consensus recommendations for the use of FEIBA® in haemophilia A patients with inhibitors undergoing elective orthopaedic and non-orthopaedic surgery

Haemophilia

Volumn 19, Issue 2, 2013, Pages 294-303

  Rangarajan, S ^a,b   Austin, S ^c   Goddard, N J ^d   Negrier C ^e   Rodriguez Merchan, E C ^f,g   Stephensen, D ^h   Yee, T T ^d  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b BASINGSTOKE AND NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d ROYAL FREE HOSPITAL   (United Kingdom)

^e EDOUARD HERRIOT HOSPITAL   (France)

^f HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^g AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

^h KENT AND CANTERBURY HOSPITAL   (United Kingdom)

Author keywords

Activated prothrombin complex concentrates; Bypassing agents; FEIBA; Haemophilia; Inhibitors; Surgery

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; ADRENALIN; LIDOCAINE; THROMBIN;

ARTICLE; CONSENSUS; FUNCTIONAL ASSESSMENT; HEMOPHILIA A; HUMAN; MORBIDITY; PHYSICAL EXAMINATION; PHYSIOTHERAPY; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUALITY OF LIFE; SURGICAL PATIENT; THROMBOCYTE FREE PLASMA; THROMBOEMBOLISM; TOURNIQUET; TREATMENT PLANNING; WOUND HEALING;

AUTOANTIBODIES; BLOOD COAGULATION FACTORS; BLOOD LOSS, SURGICAL; COAGULANTS; CONSENSUS; HEMOPHILIA A; HEMORRHAGE; HEMOSTASIS, SURGICAL; HEMOSTATICS; HUMANS; ORTHOPEDIC PROCEDURES; SURGICAL PROCEDURES, ELECTIVE;

EID: 84874032328     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12028     Document Type: Article

References (44)

1. Teitel JM, Carcao M, Lillicrap D, Mulder K, Rivard GE, St-Louis J et al. Orthopaedic surgery in haemophilia patients with inhibitors: a practical guide to haemostatic, surgical and rehabilitative care. Haemophilia 2009; 15: 227-39.
2. Négrier C, Goudemand J, Sultan Y, Bertrand M, Rothschild C, Lauroua P. Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. French FEIBA Study Group. Factor Eight Bypassing Activity. Thromb Haemost 1997; 77: 1113-9.
3. Duthie RB. Reconstructive surgery and joint replacement. In: Duthie RB, Giangrande PLF, Dodd CAF eds. The Management of Musculoskeletal Problems in the Haemophilias. Oxford: Oxford University Press, 1994: 191-215.
4. Quintana-Molina M, Martínez-Bahamonde F, González-García E, Romero-Garrido J, Villar-Camacho A, Jiménez-Yuste V et al. Surgery in haemophilic patients with inhibitor: 20 years of experience. Haemophilia 2004; 10(Suppl. 2): 30-40.
5. Giangrande PL, Wilde JT, Madan B, Ludlam CA, Tuddenham EG, Goddard NJ et al. Consensus protocol for the use of recombinant activated factor VII [eptagog alfa (activated): Novo Seven] in elective orthopaedic surgery in haemophilic patients with inhibitors. Haemophilia 2009; 15: 501-8.
6. ®) for post-operative haemostasis in a patient with high responding factor VIII inhibitors. Haemophilia 1995; 1: 274-6.
7. ®) treatment during surgery in patients with inhibitors to factor VIII/IX: the updated Norwegian experience. Haemophilia 2004; 10(Suppl. 2): 41-5.
8. Stine KC, Shrum D, Becton DL. Use of FEIBA for invasive or surgical procedures in patients with severe hemophilia A or B with inhibitors. J Pediatr Hematol Oncol 2007; 29: 216-21.
9. Holme PA. How to handle major surgery in inhibitor patients using factor eight inhibitor bypassing activity (FEIBA). Haemophilia 2009; 15: 621. Abstract.
10. Rangarajan S, Yee T, Wilde J. Experience of four UK comprehensive care centres using FEIBA for surgeries in patients with inhibitors. Haemophilia 2011; 17: 21-34.
11. Ehrlich HJ, Henzl MJ, Gomperts ED. Safety of factor VIII inhibitor bypass activity (FEIBA): 10-year compilation of thrombotic adverse events. Haemophilia 2002; 8: 83-90.
12. Aledort LM. Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity. J Thromb Haemost 2004; 2: 1700-8.
13. Kraut EH, Aledort LM, Arkin S, Stine KC, Wong WY. Surgical interventions in a cohort of patients with haemophilia A and inhibitors: an experiential retrospective chart review. Haemophilia 2007; 13: 508-17.
14. Goudemand J, Tagariello G, Lopaciuk F. Cases of surgery in high-responder haemophilia patients. Haemophilia 2004; 10(Suppl. 2): 46-9.
15. Lauroua P, Ferrer AM, Guerin V. Successful major and minor surgery using factor VIII inhibitor bypassing activity in patients with haemophilia A and inhibitors. Haemophilia 2009; 15: 1300-7.
16. Rodriguez-Merchan EC, Jimenez-Yuste V, Gomez-Cardero P, Alvarez-Roman M, Martin-Salces M, Rodriguez De La Rua A. Surgery in haemophilia patients with inhibitors, with special emphasis on orthopaedics: Madrid experience. Haemophilia 2010; 16: 84-8.
17. Balkan C, Karapinar D, Aydogdu S, Ozcan C, Ay Y, Akin M et al. Surgery in patients with haemophilia and high responding inhibitors: Izmir experience. Haemophilia 2010; 16: 902-9.
18. Caviglia H, Candela M, Galatro G, Neme D, Moretti N, Bianco RP. Elective orthopaedic surgery for haemophilia patients with inhibitors: single centre experience of 40 procedures and review of the literature. Haemophilia 2011; 17: 910-9.
19. Zülfikar B, Aydogan G, Salcioglu Z, Oner AF, Kavakli K, Gursel T et al. Efficacy of FEIBA for acute bleeding and surgical haemostasis in haemophilia A patients with inhibitors: a multicentre registry in Turkey. Haemophilia 2012; 18: 383-91. [Epub ahead of print 2011]
20. Négrier C, Pousse M, Fleury R, Hoots K, Gajek H, Berg R et al. Surgical interventions with FEIBA (SURF) - Studying the feasibility of surgery in inhibitor patients. Poster presented at the International Society on Thrombosis and Haemostasis Congress, Boston, MA, USA, 2009.
21. Dargaud Y, Lienhart A, Meunier S, Hequet O, Chavanne H, Chamouard V et al. Major surgery in a severe haemophilia A patient with high titre inhibitor: use of the thrombin generation test in the therapeutic decision. Haemophilia 2005; 11: 552-8.
22. Dargaud Y, Lienhart A, Negrier C. Prospective assessment of thrombin generation test for dose monitoring of bypassing therapy in hemophilia patients with inhibitors undergoing elective surgery. Blood 2010; 116: 5734-7.
23. Hilliard P, Funk S, Zourikian N, Bergstrom B, Bradley C, McLimont M et al. Haemophilia joint health score reliability study. Haemophilia 2006; 12: 518-25.
24. Manco-Johnson M, Nuss R, Funk S, Murphy J. Joint evaluation instruments for children and adults with haemophilia. Haemophilia 2000; 6: 649-57.
25. Stephensen D. Rehabilitation of patients with haemophilia after orthopaedic surgery: a case study. Haemophilia 2005; 11(Suppl. 1): 26-9.
26. FEIBA® SmPC, United Kingdom: Baxter Healthcare Ltd, Thetford, 2012.
27. Dai L, Bevan D, Rangarajan S, Sørensen B, Mitchell M. Stabilization of fibrin clots by activated prothrombin complex concentrate and tranexamic acid in FVIII inhibitor plasma. Haemophilia 2011; 17: e944-8.
28. ®) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A - a two-centre experience. Haemophilia 2012; 18: 544-9.
29. Gringeri A, Fischer K, Karafoulidou A, Klamroth P, López-Fernández MF, Mancuso E. Sequential combined bypassing therapy is safe and effective in the treatment of unresponsive bleeding in adults and children with haemophilia and inhibitors. Haemophilia 2011; 17: 630-5.
30. Soucie JM, Cianfrini C, Janco RL, Kulkarni R, Hambleton J, Evatt B et al. Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factors. Blood 2004; 103: 2467-73.
31. Gringeri A, Mantovani LG, Scalone L. COCIS Study Group. Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group. Blood 2003; 102: 2358-63.
32. Scalone L, Mantovani LG, Mannucci PM, Gringeri A and the COCIS Study Investigators. Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors. Haemophilia 2006; 12: 154-62.
33. Morfini M, Haya S, Tagariello G, Pollmann H, Quintana M, Siegmund B et al. European study on orthopaedic status of haemophilia patients with inhibitors. Haemophilia 2007; 13: 606-12.
34. Perry D, Berntorp E, Tait C, Dolan G, Holme PA, Laffan M et al. FEIBA prophylaxis in haemophilia patients: a clinical update and treatment recommendations. Haemophilia 2010; 16: 80-9.
35. Leissinger C, Gringeri A, Antmen B, Berntorp E, Biasoli C, Carpenter S et al. Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors. N Eng J Med 2011; 365: 1684-92.
36. Aledort LM, Haschmetyer RH, Pettersson H. A longitudinal study of orthopaedic outcomes for severe factor VIII-deficient haemophiliacs. The orthopaedic outcome study group. J Intern Med 1994; 236: 391-9.
37. Siboni SM, Mannucci PM, Gringeri A, Franchini M, Tagliaferri A, Ferretti M. Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy. J Thromb Haemost 2009; 7: 780-6.
38. Di Minno MND, Di Minno G, Di Capua M, Cerbone AM, Coppola A. Cost of care of haemophilia with inhibitors. Haemophilia 2010; 16: e190-201.
39. Bonnet PO, Yoon BS, Wong WY, Boswell K, Ewenstein BM. Cost minimization analysis to compare activated prothrombin complex concentrate (APCC) and recombinant factor VIIa for haemophilia patients with inhibitors undergoing major orthopaedic surgeries. Haemophilia 2009; 15: 1083-9.
40. Rodriguez-Merchan EC, Rocino A, Ewenstein B, Bartha L, Batorova A, Goudemand J et al. Consensus perspectives on surgery in haemophilia patients with inhibitors: summary statement. Haemophilia 2004; 10(Suppl. 2): 50-2.
41. DiMichele D, Négrier C. A retrospective post licensure survey of FEIBA efficacy and safety. Haemophilia 2006; 12: 352-62.
42. Tjønnfjord GE. Surgery in patients with haemophilia and inhibitors: a review of the Norwegian experience with FEIBA. Semin Hematol 2006; 43(Suppl. 4): S18-21.
43. Rodriguez-Merchan EC, Quintana M, Jimenez-Yuste V, Hernández-Navarro F. Orthopaedic surgery for inhibitor patients: a series of 27 procedures (25 patients). Haemophilia 2007; 13: 613-9.
44. Pettersson H, Gilbert MS. Clinical and radiological evaluations of hemophilic arthropathy. In: Pettersson H, Gilbert MS eds. Diagnostic Imaging in Hemophilia. Berlin: Springer-Verlag, 1985: 56-68.